Greg Wasson
About Greg Wasson
Greg Wasson (age 66) is an independent Class I director of P3 Health Partners Inc. (PIII), serving since 2020. He is the former President and CEO of Walgreens Boots Alliance, Inc., where he spent 34 years and led Walgreens to record FY2014 sales of $76.4B, and is the founder of Wasson Enterprise (2016–present). He holds a pharmacy degree from Purdue University’s School of Pharmacy. His healthcare retail and large‑scale operations background underpins his board contributions at PIII.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Walgreens / Walgreens Boots Alliance | President & CEO; earlier senior roles over 34 years | Culminated in FY2014 record sales ($76.4B) | Led transformative Alliance Boots merger; built diverse senior team; executed complex organizational change |
| Foresight Acquisition Corp (PIII’s predecessor) | Director | Since Nov 2020 | Continuity into de‑SPAC; board governance through transition |
External Roles
| Organization | Role | Tenure | Committees/Notes |
|---|---|---|---|
| OptimizeRx Corp (NASDAQ: OPRX) | Director | Since Aug 2020 | Public company board experience in digital health |
| PNC Financial Services Group (NYSE: PNC) | Director (prior) | Jul 2015 – Oct 2018 | Large‑cap financial sector oversight |
| Verizon Communications (NYSE: VZ) | Director (prior) | Feb 2013 – Oct 2018 | Fortune 100 telecom/tech governance experience |
| Wasson Enterprise (family office) | President & Founder | Since 2016 | Partners with entrepreneurs to build high‑growth businesses |
Board Governance
- Independence and leadership
- Independent director under Nasdaq rules; Board majority independent; independent Chair (Mark Thierer). Independent directors meet in executive session at least twice per year, chaired by the Board Chair.
- Committee assignments and expertise
- Audit Committee member; Compensation & Nominating Committee member (not Chair). Audit met 6 times in 2024; Compensation & Nominating met 5 times. The Board met 8 times; each director attended at least 75% of applicable meetings in 2024.
- Audit Committee chair is Jeffrey G. Park; Park designated “audit committee financial expert”; all members (including Wasson) meet Nasdaq financial literacy standards.
- 2025 shareholder votes (signals of support)
- Re‑elected Class I director on June 4, 2025: For 209,589,112; Withheld 4,914,153; Broker non‑votes 19,312,493. Say‑on‑pay For 211,787,285; Against 2,699,161; Abstain 16,819; Broker non‑votes 19,312,493.
Fixed Compensation
| Component (Non‑Employee Director Program) | Amount (USD) | Notes |
|---|---|---|
| Annual cash retainer | $65,000 | Paid quarterly; prorated for partial service |
| Committee member retainer – Audit | $12,500 | Member (non‑chair) |
| Committee member retainer – Compensation & Nominating | $12,500 | Member (non‑chair) |
| Total cash fees received (2024) | $90,000 | As reported for Greg Wasson |
Performance Compensation
| Equity Element | Grant/Value | Vesting/Performance | Year‑End Holdings (12/31/2024) |
|---|---|---|---|
| Annual option grant | $170,049 (grant‑date fair value) | Vests in full on earlier of first anniversary or next annual meeting; time‑based, no performance conditions | Options: 568,175 (vested+unvested); RSUs: 108,281 unvested (counts pre‑reverse split) |
Program design: Each Eligible Director automatically receives an annual option grant at the annual meeting sized to FMV $170,000 (Chair $340,000), vesting as noted above. No meeting fees; compensation subject to plan limits.
Other Directorships & Interlocks
| Company | Type | Role/Status | Potential Interlock with PIII |
|---|---|---|---|
| OptimizeRx (OPRX) | Public | Current Director (since Aug 2020) | None disclosed with PIII customers/suppliers |
| PNC Financial (PNC) | Public | Former Director (2015–2018) | None disclosed |
| Verizon (VZ) | Public | Former Director (2013–2018) | None disclosed |
- Company‑level sponsor influence context: Chicago Pacific Founders (CPF) is principal stockholder; CPF has a letter agreement right to designate an additional independent director while owning ≥40% (standing extended to Jan 1, 2026). Not specific to Wasson, but relevant to overall board dynamics.
Expertise & Qualifications
- Deep healthcare retail and supply chain operations; led Walgreens’ global expansion (Alliance Boots), complex M&A and organizational integrations.
- Financial literacy and audit oversight through Audit Committee service; compensation governance through Compensation & Nominating Committee.
- Anti‑hedging policy applies to directors, reinforcing alignment (prohibits hedging instruments).
- Degrees: Pharmacy (Purdue University).
Equity Ownership
| Ownership Component (Class A, pre‑reverse split counts where applicable) | Shares |
|---|---|
| Direct Class A shares | 108,280 |
| Options exercisable within 60 days | 568,175 |
| Indirect: G&K Investment Holdings LLC (controlled by G. Wasson) | 859,648 |
| Total beneficial ownership (Class A) | 1,536,103 |
| % of outstanding | <1% |
Notes:
- Beneficial ownership table and director equity footnotes indicate figures are not adjusted for the 1‑for‑50 reverse stock split; the proxy explicitly notes certain sections (including director equity tables) are presented pre‑split.
- Insider Trading & Anti‑Hedging Policy prohibits hedging by directors and entities they control.
Governance Assessment
- Signals supporting investor confidence
- Independence and active committee service: Wasson serves on both Audit and Compensation & Nominating, with all audit members independent and financially literate; independent Chair structure with regular executive sessions.
- Strong re‑election and say‑on‑pay outcomes at 2025 AGM, indicating broad shareholder support.
- Director pay mix emphasizes equity via annual options (time‑based vesting), and cash fees are modest relative to equity, aligning with long‑term performance.
- No Section 16(a) filing delinquencies identified for Wasson in 2024 (others listed; Wasson not among them).
- Potential conflicts and mitigants
- Company‑level related‑party financing: 2025 VBC 4 warrants/notes with a CPF affiliate were approved by an independent, disinterested director committee, then the full board; shareholder approval obtained for warrant share issuance (Proposal 4). This mitigates sponsor‑related conflict risks.
- Sponsor influence remains material: CPF retains rights to designate an additional independent director while maintaining significant ownership; governance focus on independent oversight is critical (Wasson’s dual committee roles are supportive).
- RED FLAGS
- None specific to Greg Wasson identified in PIII’s latest proxy and AGM results (no attendance shortfalls disclosed; no related‑party transactions linked to him; no hedging/pledging disclosures involving him).